You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Details for New Drug Application (NDA): 206099


✉ Email this page to a colleague

« Back to Dashboard


NDA 206099 describes ONZETRA XSAIL, which is a drug marketed by Currax and is included in one NDA. It is available from one supplier. There are sixteen patents protecting this drug. Additional details are available on the ONZETRA XSAIL profile page.

The generic ingredient in ONZETRA XSAIL is sumatriptan succinate. There are twenty-four drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.
Summary for 206099
Tradename:ONZETRA XSAIL
Applicant:Currax
Ingredient:sumatriptan succinate
Patents:16
Pharmacology for NDA: 206099
Suppliers and Packaging for NDA: 206099
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ONZETRA XSAIL sumatriptan succinate POWDER;NASAL 206099 NDA Currax Pharmaceuticals LLC 42847-311 42847-311-08 8 POUCH in 1 CARTON (42847-311-08) / 2 CAPSULE in 1 POUCH

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;NASALStrengthEQ 11MG BASE
Approval Date:Jan 27, 2016TE:RLD:Yes
Patent:⤷  Sign UpPatent Expiration:Oct 20, 2034Product Flag?YSubstance Flag?Delist Request?
Patent:⤷  Sign UpPatent Expiration:Jul 30, 2029Product Flag?Substance Flag?Delist Request?
Patented Use:ACUTE TREATMENT OF MIGRAINE BY DELIVERING A POWDERED SUBSTANCE COMPRISING SUMATRIPTAN VIA A BREATH-POWERED DELIVERY DEVICE
Patent:⤷  Sign UpPatent Expiration:Jul 30, 2029Product Flag?Substance Flag?Delist Request?
Patented Use:METHOD OF DELIVERING SUMATRIPTAN TO A NASAL CAVITY

Expired US Patents for NDA 206099

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Currax ONZETRA XSAIL sumatriptan succinate POWDER;NASAL 206099-001 Jan 27, 2016 ⤷  Sign Up ⤷  Sign Up
Currax ONZETRA XSAIL sumatriptan succinate POWDER;NASAL 206099-001 Jan 27, 2016 ⤷  Sign Up ⤷  Sign Up
Currax ONZETRA XSAIL sumatriptan succinate POWDER;NASAL 206099-001 Jan 27, 2016 ⤷  Sign Up ⤷  Sign Up
Currax ONZETRA XSAIL sumatriptan succinate POWDER;NASAL 206099-001 Jan 27, 2016 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.